ExodusPoint Capital Management »

Alpine Immune Sciences shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.8M 171k 39.64
2023-09-30 $2.5M 217k 11.45
2023-06-30 $646k 63k 10.28
2021-03-31 $385k 36k 10.59
2020-12-31 $1.1M 90k 12.60

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Meta Platforms Cl A (META)
Global Payments (GPN)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NiSource (NI)
PPL Corporation (PPL)
Intel Corporation (INTC)
Marvell Technology (MRVL)
Exxon Mobil Corporation (XOM)

View all positions for ExodusPoint Capital Management

Top funds holding Alpine Immune Sciences

Decheng Capital
venBio Select Advisor
BlackRock
Frazier Life Sciences Management
T. Rowe Price Associates
State Street Corporation
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
Lynx1 Capital Management
Paradigm Biocapital Advisors
Darwin Global Management
Commodore Capital
Octagon Capital Advisors
Avidity Partners Management

View all funds holding Alpine Immune Sciences